YARROW BIOSCIENCE, INC. Interest Income (Expense), Nonoperating, Net
YARROW BIOSCIENCE, INC. (YARW) reported Interest Income (Expense), Nonoperating, Net of $433.00 thousand for the 3-month period ending 2019-12-31, per its 10-K filed 2020-03-03.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNonoperatingNet · last filed 2020-03-03
- YARROW BIOSCIENCE, INC. interest income (expense), nonoperating, net for the quarter ending 2019-12-31 was $433.00K, a 48.82% decline year-over-year.
- YARROW BIOSCIENCE, INC. interest income (expense), nonoperating, net for the quarter ending 2019-09-30 was $571.00K, a 33.22% decline year-over-year.
- YARROW BIOSCIENCE, INC. interest income (expense), nonoperating, net for the quarter ending 2019-06-30 was $739.00K, a 10.53% decline year-over-year.
- YARROW BIOSCIENCE, INC. interest income (expense), nonoperating, net for the quarter ending 2019-03-31 was $796.00K, a 41.39% increase year-over-year.
- YARROW BIOSCIENCE, INC. interest income (expense), nonoperating, net for fiscal 2017 was $517.00K, a 95.83% increase from fiscal 2016.
- YARROW BIOSCIENCE, INC. interest income (expense), nonoperating, net for fiscal 2016 was $264.00K.
- YARROW BIOSCIENCE, INC. interest income (expense), nonoperating, net for fiscal 2015 was $0.00.
| Period end | Interest Income (Expense), Nonoperating, Net 3 month | Interest Income (Expense), Nonoperating, Net 3 month as first filed | Interest Income (Expense), Nonoperating, Net 6 month | Interest Income (Expense), Nonoperating, Net 9 month | Interest Income (Expense), Nonoperating, Net 12 month |
|---|---|---|---|---|---|
| 2019-12-31 | $433.00K 10-K · filed 2020-03-03 | $1.00M derived: sum of 2 quarters · filed 2020-03-03 | $1.74M derived: sum of 3 quarters · filed 2020-03-03 | $2.54M derived: sum of 4 quarters · filed 2020-03-03 | |
| 2019-09-30 | $571.00K 10-K · filed 2020-03-03 | $1.31M derived: sum of 2 quarters · filed 2020-03-03 | $2.11M derived: sum of 3 quarters · filed 2020-03-03 | $2.95M derived: sum of 4 quarters · filed 2020-03-03 | |
| 2019-06-30 | $739.00K 10-K · filed 2020-03-03 | $1.53M derived: sum of 2 quarters · filed 2020-03-03 | $2.38M derived: sum of 3 quarters · filed 2020-03-03 | $3.24M derived: sum of 4 quarters · filed 2020-03-03 | |
| 2019-03-31 | $796.00K 10-K · filed 2020-03-03 | $1.64M derived: sum of 2 quarters · filed 2020-03-03 | $2.50M derived: sum of 3 quarters · filed 2020-03-03 | $3.32M derived: sum of 4 quarters · filed 2020-03-03 | |
| 2018-12-31 | $846.00K 10-K · filed 2020-03-03 | $1.70M derived: sum of 2 quarters · filed 2020-03-03 | $2.53M derived: sum of 3 quarters · filed 2020-03-03 | $3.09M derived: sum of 4 quarters · filed 2020-03-03 | |
| 2018-09-30 | $855.00K 10-K · filed 2020-03-03 | $1.68M derived: sum of 2 quarters · filed 2020-03-03 | $2.24M derived: sum of 3 quarters · filed 2020-03-03 | $2.44M derived: sum of 4 quarters · filed 2020-03-03 | |
| 2018-06-30 | $826.00K 10-K · filed 2020-03-03 | $1.39M 10-Q · filed 2018-08-01 | $1.59M derived: sum of 3 quarters · filed 2020-03-03 | $1.75M derived: sum of 4 quarters · filed 2020-03-03 | |
| 2018-03-31 | $563.00K 10-K · filed 2020-03-03 | $763.00K derived: sum of 2 quarters · filed 2020-03-03 | $926.00K derived: sum of 3 quarters · filed 2020-03-03 | $998.00K derived: sum of 4 quarters · filed 2020-03-03 | |
| 2017-12-31 | $200.00K 10-K · filed 2019-02-28 | $363.00K derived: sum of 2 quarters · filed 2019-02-28 | $435.00K derived: sum of 3 quarters · filed 2019-02-28 | $517.00K 10-K · filed 2018-03-28 | |
| 2017-09-30 | $163.00K 10-K · filed 2019-02-28 | $235.00K derived: sum of 2 quarters · filed 2019-02-28 | $316.00K derived: sum of 3 quarters · filed 2019-02-28 | $404.00K derived: sum of 4 quarters · filed 2019-02-28 | |
| 2017-06-30 | $72.00K 10-K · filed 2019-02-28 | $73.00K 10-K · filed 2018-03-28 | $153.00K 10-Q · filed 2018-08-01 | $241.00K derived: sum of 3 quarters · filed 2019-02-28 | $318.00K derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $81.00K 10-K · filed 2019-02-28 | $169.00K derived: sum of 2 quarters · filed 2019-02-28 | $246.00K derived: sum of 3 quarters · filed 2019-02-28 | $320.00K derived: sum of 4 quarters · filed 2019-02-28 | |
| 2016-12-31 | $88.00K 10-K · filed 2018-03-28 | $165.00K derived: sum of 2 quarters · filed 2018-03-28 | $239.00K derived: sum of 3 quarters · filed 2018-03-28 | $264.00K 10-K · filed 2018-03-28 | |
| 2016-09-30 | $77.00K 10-K · filed 2018-03-28 | $151.00K derived: sum of 2 quarters · filed 2018-03-28 | $176.00K derived: sum of 3 quarters · filed 2018-03-28 | ||
| 2016-06-30 | $74.00K 10-K · filed 2018-03-28 | $99.00K derived: sum of 2 quarters · filed 2018-03-28 | |||
| 2016-03-31 | $25.00K 10-K · filed 2018-03-28 | ||||
| 2015-12-31 | $0.00 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |